STOCK TITAN

R. LaDuane Clifton (ZVRA) files Form 144 showing 11,000‑ and 3,000‑share sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

R. LaDuane Clifton reported proposed dispositions of Common Stock under a Form 144, including sales disclosed for 02/03/2026 of 11,000 shares and for 01/30/2026 of 3,000 shares.

The filing lists multiple prior and scheduled issuances or vesting events (restricted stock vesting and previously exercised options) with amounts shown in the excerpt, including a 230,306 share entry for 03/10/2026 and larger vesting entries on 01/31/2025 and 12/31/2025. The filing shows addresses and broker/issuer information for the transactions.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice of proposed sale filed showing discrete recent sales and multiple vested/issuable share items.

The Form 144 excerpt documents two reported sales in the prior three months: 11,000 shares on 02/03/2026 and 3,000 shares on 01/30/2026

The filing also enumerates numerous restricted‑stock vesting entries and a 230,306 share line marked "Previously Exercised Options" dated 03/10/2026. These line items appear as the securities being offered or associated with the reporting person; timing and settlement mechanics are not detailed in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for ZVRA filed by R. LaDuane Clifton show?

The Form 144 shows proposed dispositions of Common Stock, including 11,000 shares on 02/03/2026 and 3,000 shares on 01/30/2026. It also lists multiple vesting and previously exercised option line items with amounts and dates.

Does the filing list other shares tied to vesting or exercises for ZVRA?

Yes. The excerpt lists several restricted stock vesting entries (example dates: 01/31/2025, 12/31/2025) and a 230,306 share entry labeled "Previously Exercised Options" dated 03/10/2026 as shown in the excerpt.

Who is the broker or intermediary named in the Form 144 excerpt?

The excerpt names Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004 as the listed broker/executive financial services intermediary in the filing information.

Are the amounts sold in the past three months the same as the larger vesting or exercised amounts listed?

No. The filing separately reports past three‑month sales of 11,000 and 3,000 shares, while other lines list vesting and a 230,306 share previously exercised options entry; the excerpt treats these as distinct line items.

Does the Form 144 specify how sale proceeds will be used or who receives them?

The provided excerpt does not state the use of proceeds or who receives cash from the dispositions. The filing lists the securities, dates, and broker/issuer details but does not disclose proceeds allocation in the excerpt.
Zevra Therapeutics Inc

NASDAQ:ZVRA

View ZVRA Stock Overview

ZVRA Rankings

ZVRA Latest News

ZVRA Latest SEC Filings

ZVRA Stock Data

555.66M
55.53M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON